Table 2.
Prevalence | True positive | False positive | False negative | True negative | Sensitivity (%) | Specificity (%) | PPV (%) | NPV (%) | LR+ | LR− | DOR | |
Cevidanes et al19 | 0.76 | 62 | 10 | 18 | 14 | 78.00 | 58.00 | 73.58 | 63.73 | 1.85 | 0.37 | 4.89 |
Dias et al21 | 0.40 | 10 | 2 | 9 | 26 | 53.00 | 93.00 | 88.33 | 66.42 | 7.57 | 0.50 | 14.98 |
Kim et al20 b | 0.41 | 180 | 278 | 129 | 152 | 58.00 | 35.00 | 47.15 | 45.45 | 0.89 | 1.20 | 0.74 |
Talaat et al22 | 0.31 | 36 | 31 | 4 | 55 | 90.00 | 64.00 | 71.42 | 86.48 | 2.50 | 0.15 | 16.00 |
DOR, diagnostic odds ratio; LR, likelihood ratio; NPV, negative predicative value; PPV, positive predicative value.
studies using CBCT.
study using CT.